Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Poplack

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
Journal of the National Cancer Institute|January 19, 1994
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusionS L Berg, K H Cowan, F M Balis, et al.
Leukemia|June 1, 1994
Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutationsC A Felix, R Wasserman, B J Lange, et al.
Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.
Cancer Treatment Reports|June 1, 1982
Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeysJ P McGovren, J C Stewart, G L Elfring, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.
Cancer Research|November 15, 1991
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic studyP C Adamson, F M Balis, C A Arndt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemiaP C Adamson, S Zimm, A H Ragab, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primatesT J Walsh, C Lester-McCully, M G Rinaldi, et al.
Clinical Pharmacology and Therapeutics|April 1, 1987
The effect of methotrexate on the bioavailability of oral 6-mercaptopurineF M Balis, J S Holcenberg, S Zimm, et al.
Cancer Treatment Reports|December 1, 1978
Combined modality treatment of Burkitt's lymphomaJ L Ziegler, I T Magrath, A B Deisseroth, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Journal of the National Cancer Institute|January 19, 1994
Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusionS L Berg, K H Cowan, F M Balis, et al.
Leukemia|June 1, 1994
Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutationsC A Felix, R Wasserman, B J Lange, et al.
Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.
Cancer Treatment Reports|June 1, 1982
Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeysJ P McGovren, J C Stewart, G L Elfring, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.
Cancer Research|November 15, 1991
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic studyP C Adamson, F M Balis, C A Arndt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemiaP C Adamson, S Zimm, A H Ragab, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primatesT J Walsh, C Lester-McCully, M G Rinaldi, et al.
Clinical Pharmacology and Therapeutics|April 1, 1987
The effect of methotrexate on the bioavailability of oral 6-mercaptopurineF M Balis, J S Holcenberg, S Zimm, et al.
Cancer Treatment Reports|December 1, 1978
Combined modality treatment of Burkitt's lymphomaJ L Ziegler, I T Magrath, A B Deisseroth, et al.
Pageof 23